Jung‐Hwan Yoon

20.5k total citations · 3 hit papers
425 papers, 13.6k citations indexed

About

Jung‐Hwan Yoon is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jung‐Hwan Yoon has authored 425 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 265 papers in Hepatology, 248 papers in Epidemiology and 77 papers in Surgery. Recurrent topics in Jung‐Hwan Yoon's work include Liver Disease Diagnosis and Treatment (195 papers), Hepatocellular Carcinoma Treatment and Prognosis (134 papers) and Hepatitis B Virus Studies (114 papers). Jung‐Hwan Yoon is often cited by papers focused on Liver Disease Diagnosis and Treatment (195 papers), Hepatocellular Carcinoma Treatment and Prognosis (134 papers) and Hepatitis B Virus Studies (114 papers). Jung‐Hwan Yoon collaborates with scholars based in South Korea, Ethiopia and United States. Jung‐Hwan Yoon's co-authors include Yoon Jun Kim, Jeong‐Hoon Lee, Su Jong Yu, Won Kim, Hyo-Suk Lee, Gregory J. Gores, Eun Ju Cho, Donghee Kim, Goh Eun Chung and Chung Yong Kim and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Jung‐Hwan Yoon

405 papers receiving 13.4k citations

Hit Papers

Hepatic steatosis index: ... 2009 2026 2014 2020 2009 2021 2024 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
    2009 1.1k citations Jeong‐Hoon Lee, Won Kim et al. profile →
  2. Liver homeostasis is maintained by midlobular zone 2 hepatocytes
    2021 163 citations Jung‐Hwan Yoon et al. profile →
  3. EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization.
    2024 93 citations Masatoshi Kudo, Shukui Qin et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jung‐Hwan Yoon 6.8k 6.7k 2.8k 2.8k 2.1k 425 13.6k
Michio Sata 7.1k 1.1× 6.8k 1.0× 3.1k 1.1× 2.6k 0.9× 2.1k 1.0× 457 15.1k
Jean‐François Dufour 7.7k 1.1× 8.5k 1.3× 3.0k 1.1× 2.1k 0.8× 1.3k 0.6× 342 14.4k
James G. Kench 3.7k 0.6× 6.4k 1.0× 2.6k 0.9× 2.5k 0.9× 2.5k 1.2× 168 11.9k
Markus Peck‐Radosavljevic 9.7k 1.4× 8.4k 1.3× 1.9k 0.7× 3.1k 1.1× 1.8k 0.8× 376 14.7k
Swan N. Thung 7.5k 1.1× 6.4k 1.0× 4.2k 1.5× 4.3k 1.5× 2.9k 1.4× 320 17.0k
Takeshi Okanoue 6.2k 0.9× 8.7k 1.3× 3.9k 1.4× 2.3k 0.8× 1.3k 0.6× 390 15.5k
Masahiro Kobayashi 11.3k 1.7× 9.8k 1.5× 1.7k 0.6× 1.4k 0.5× 1.7k 0.8× 473 15.3k
Joel K. Greenson 3.6k 0.5× 5.7k 0.9× 2.9k 1.0× 4.3k 1.6× 4.3k 2.0× 201 15.8k
Michael Torbenson 9.2k 1.4× 12.7k 1.9× 5.8k 2.1× 4.0k 1.4× 2.3k 1.1× 297 22.7k
Christian P. Strassburg 4.9k 0.7× 4.5k 0.7× 2.9k 1.1× 3.0k 1.1× 2.2k 1.0× 355 13.0k

Countries citing papers authored by Jung‐Hwan Yoon

Since Specialization
Citations

This map shows the geographic impact of Jung‐Hwan Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Hwan Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Hwan Yoon more than expected).

Fields of papers citing papers by Jung‐Hwan Yoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Hwan Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Hwan Yoon. The network helps show where Jung‐Hwan Yoon may publish in the future.

Co-authorship network of co-authors of Jung‐Hwan Yoon

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Hwan Yoon. A scholar is included among the top collaborators of Jung‐Hwan Yoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Hwan Yoon. Jung‐Hwan Yoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Sung Won, Min Kyung Park, Xiao Zhang, et al.. (2024). The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea. Canadian Journal of Gastroenterology and Hepatology. 2024(1). 5667986–5667986.
2.
Kim, Jae Hyun, Jeong Hee Yoon, Junghoan Park, et al.. (2024). No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments. Korean Journal of Radiology. 25(5). 438–438. 1 indexed citations
3.
Kim, Seung Up, Hyun Woong Lee, Han Ah Lee, et al.. (2024). FRI-397 A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B. Journal of Hepatology. 80. S774–S775.
4.
Cho, Eun Ju, Su‐Min Jeong, Goh Eun Chung, et al.. (2023). Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study. Scientific Reports. 13(1). 1751–1751. 20 indexed citations
5.
6.
Noh, Ji Yun, June‐Young Koh, Sung Won Chung, et al.. (2023). COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B. Immune Network. 23(5). e39–e39. 1 indexed citations
7.
Chung, Goh Eun, Eun Ju Cho, Min Joo Kim, et al.. (2023). Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years: a nationwide population-based study. Frontiers in Endocrinology. 14. 1156996–1156996. 3 indexed citations
8.
Park, Byung‐Jun, et al.. (2023). Effects of Additives on Greenhouse Gas Emission during Organic Waste Composting. Korean Journal of Environmental Agriculture. 42(4). 358–370.
9.
Chung, Sung Won, Min Kyung Park, Young Youn Cho, et al.. (2021). Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of Hepatocellular Carcinoma. Volume 8. 587–598. 2 indexed citations
10.
Kim, Byoung Hyuck, et al.. (2021). Role of radiotherapy in Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma treated with sorafenib. Journal of Gastroenterology and Hepatology. 37(2). 387–394. 11 indexed citations
11.
Jang, Heejoon, Joon Yeul Nam, Yun Bin Lee, et al.. (2021). Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study. SHILAP Revista de lepidopterología. Volume 8. 1565–1577. 11 indexed citations
12.
Okusaka, Takuji, Kenji Ikeda, Masatoshi Kudo, et al.. (2021). Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT. Journal of Gastroenterology. 56(6). 570–580. 10 indexed citations
13.
Lee, Dae-Won, Eun Ju Cho, Su Jong Yu, et al.. (2020). Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib. Clinical Cancer Research. 27(3). 713–718. 33 indexed citations
14.
Yoon, Jun Sik, Dong Ho Lee, Eun Ju Cho, et al.. (2020). Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance. Cancers. 12(7). 1805–1805. 25 indexed citations
15.
Cho, Eun Ju, Sangseob Leem, Sunah Kim, et al.. (2019). Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma. Scientific Reports. 9(1). 7536–7536. 72 indexed citations
16.
Kang, Seong Hee, Yun Bin Lee, Jeong‐Hoon Lee, et al.. (2017). Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. Alimentary Pharmacology & Therapeutics. 46(9). 845–855. 61 indexed citations
17.
Cho, Hyeki, Yuri Cho, Eun Ju Cho, et al.. (2016). Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases. Clinical and Molecular Hepatology. 22(2). 286–291. 11 indexed citations
18.
19.
Woo, Hyun Goo, Jeong‐Hoon Lee, Jung‐Hwan Yoon, et al.. (2010). Identification of a Cholangiocarcinoma-Like Gene Expression Trait in Hepatocellular Carcinoma. Cancer Research. 70(8). 3034–3041. 149 indexed citations
20.
Woo, Hyun Goo, Eun Sung Park, Jae Hee Cheon, et al.. (2008). Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma. Clinical Cancer Research. 14(7). 2056–2064. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michio Sata Breakdown of academic impact, for papers by Jean‐François Dufour Breakdown of academic impact, for papers by James G. Kench Breakdown of academic impact, for papers by Markus Peck‐Radosavljevic Breakdown of academic impact, for papers by Swan N. Thung Breakdown of academic impact, for papers by Takeshi Okanoue Breakdown of academic impact, for papers by Masahiro Kobayashi Breakdown of academic impact, for papers by Joel K. Greenson Breakdown of academic impact, for papers by Michael Torbenson Breakdown of academic impact, for papers by Christian P. Strassburg
Rankless by CCL
2026